Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Genest

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER)Paul M Ridker, Jean G MacFadyen, Francisco A H Fonseca, et al.
The American Journal of Cardiology|November 27, 2007
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive proteinPaul M Ridker, Francisco A H Fonseca, Jacques Genest, et al.
The New England Journal of Medicine|November 11, 2008
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinPaul M Ridker, Eleanor Danielson, Francisco A H Fonseca, et al.
The New England Journal of Medicine|March 31, 2009
A randomized trial of rosuvastatin in the prevention of venous thromboembolismRobert J Glynn, Eleanor Danielson, Francisco A H Fonseca, et al.
American Journal of Epidemiology|April 14, 2009
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormonesMichael S Kramer, John Lydon, Louise Séguin, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Atherosclerosis|November 23, 2025
Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaborationG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
Atherosclerosis|September 12, 2020
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levelsKang H Zheng, Yannick Kaiser, Casper C van Olden, et al.
Journal of Clinical Lipidology|January 28, 2024
Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemiaZobaida Al-Baldawi, Leslie Brown, Isabelle Ruel, et al.
Clinical Chemistry|October 18, 2017
Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or EzetimibeIsabelle Ruel, Sumayah Aljenedil, Iman Sadri, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER)Paul M Ridker, Jean G MacFadyen, Francisco A H Fonseca, et al.
The American Journal of Cardiology|November 27, 2007
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive proteinPaul M Ridker, Francisco A H Fonseca, Jacques Genest, et al.
The New England Journal of Medicine|November 11, 2008
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinPaul M Ridker, Eleanor Danielson, Francisco A H Fonseca, et al.
The New England Journal of Medicine|March 31, 2009
A randomized trial of rosuvastatin in the prevention of venous thromboembolismRobert J Glynn, Eleanor Danielson, Francisco A H Fonseca, et al.
American Journal of Epidemiology|April 14, 2009
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormonesMichael S Kramer, John Lydon, Louise Séguin, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Atherosclerosis|November 23, 2025
Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaborationG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
Atherosclerosis|September 12, 2020
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levelsKang H Zheng, Yannick Kaiser, Casper C van Olden, et al.
Journal of Clinical Lipidology|January 28, 2024
Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemiaZobaida Al-Baldawi, Leslie Brown, Isabelle Ruel, et al.
Clinical Chemistry|October 18, 2017
Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or EzetimibeIsabelle Ruel, Sumayah Aljenedil, Iman Sadri, et al.
Pageof 22